# Oil-Dri Corp of America: financial statements, quarterly

ODC · NYSE · CIK 74046 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Jul 31

Pages: [Overview](/companies/odc.md) · [Financials](/companies/odc/financials.md) · [Filings](/companies/odc/filings.md) · [Insiders](/companies/odc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/odc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2024 (2023-10-31) | Q2 FY2024 (2024-01-31) | Q3 FY2024 (2024-04-30) | Q4 FY2024 (2024-07-31) | Q1 FY2025 (2024-10-31) | Q2 FY2025 (2025-01-31) | Q3 FY2025 (2025-04-30) | Q4 FY2025 (2025-07-31) | Q1 FY2026 (2025-10-31) | Q2 FY2026 (2026-01-31) | Q3 FY2026 (2026-04-30) | Q4 FY2026 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [111](/filings/0000074046-24-000094.md) | [106](/filings/0000074046-25-000028.md) | [107](/filings/0000074046-25-000069.md) | [114 d](/filings/0001628280-26-065453.md) | [128](/filings/0001628280-25-055811.md) | [117](/filings/0001628280-26-016822.md) | [116](/filings/0001628280-26-041539.md) | [125 d](/filings/0001628280-26-065453.md) | [120](/filings/0001628280-25-055811.md) | [118](/filings/0001628280-26-016822.md) | [126](/filings/0001628280-26-041539.md) | [129 d](/filings/0001628280-26-065453.md) |
| Cost of revenue | $m | [80.4](/filings/0000074046-24-000094.md) | [74.7](/filings/0000074046-25-000028.md) | [76.6](/filings/0000074046-25-000069.md) | [80.7 d](/filings/0001628280-26-065453.md) | [87.2](/filings/0001628280-25-055811.md) | [82.5](/filings/0001628280-26-016822.md) | [82.5](/filings/0001628280-26-041539.md) | [90.4 d](/filings/0001628280-26-065453.md) | [85.0](/filings/0001628280-25-055811.md) | [85.4](/filings/0001628280-26-016822.md) | [92.6](/filings/0001628280-26-041539.md) | [93.3 d](/filings/0001628280-26-065453.md) |
| Gross profit | $m | [31.0](/filings/0000074046-24-000094.md) | [30.9](/filings/0000074046-25-000028.md) | [30.1](/filings/0000074046-25-000069.md) | [33.0 d](/filings/0001628280-26-065453.md) | [40.8](/filings/0001628280-25-055811.md) | [34.4](/filings/0001628280-26-016822.md) | [33.0](/filings/0001628280-26-041539.md) | [34.8 d](/filings/0001628280-26-065453.md) | [35.5](/filings/0001628280-25-055811.md) | [32.3](/filings/0001628280-26-016822.md) | [33.7](/filings/0001628280-26-041539.md) | [36.0 d](/filings/0001628280-26-065453.md) |
| Selling, general and administrative | $m | [17.8](/filings/0000074046-24-000094.md) | [15.8](/filings/0000074046-25-000028.md) | [19.7](/filings/0000074046-25-000069.md) | [20.1 d](/filings/0001628280-26-065453.md) | [19.6](/filings/0001628280-25-055811.md) | [17.0](/filings/0001628280-26-016822.md) | [19.1](/filings/0001628280-26-041539.md) | [19.2 d](/filings/0001628280-26-065453.md) | [18.5](/filings/0001628280-25-055811.md) | [16.6](/filings/0001628280-26-016822.md) | [16.6](/filings/0001628280-26-041539.md) | [17.7 d](/filings/0001628280-26-065453.md) |
| Operating income | $m | [13.2](/filings/0000074046-24-000094.md) | [15.2](/filings/0000074046-25-000028.md) | [10.4](/filings/0000074046-25-000069.md) | [12.9 d](/filings/0001628280-26-065453.md) | [21.2](/filings/0001628280-25-055811.md) | [17.5](/filings/0001628280-26-016822.md) | [13.9](/filings/0001628280-26-041539.md) | [15.6 d](/filings/0001628280-26-065453.md) | [17.0](/filings/0001628280-25-055811.md) | [15.7](/filings/0001628280-26-016822.md) | [17.1](/filings/0001628280-26-041539.md) | [18.2 d](/filings/0001628280-26-065453.md) |
| Income tax | $m | [2.1](/filings/0000074046-24-000094.md) | [2.3](/filings/0000074046-25-000028.md) | [2.4](/filings/0000074046-25-000069.md) | [3.5 d](/filings/0001628280-26-065453.md) | [3.8](/filings/0001628280-25-055811.md) | [3.3](/filings/0001628280-26-016822.md) | [2.6](/filings/0001628280-26-041539.md) | [2.4 d](/filings/0001628280-26-065453.md) | [2.2](/filings/0001628280-25-055811.md) | [3.2](/filings/0001628280-26-016822.md) | [3.4](/filings/0001628280-26-041539.md) | [3.7 d](/filings/0001628280-26-065453.md) |
| Net income | $m | [10.7](/filings/0000074046-24-000094.md) | [12.4](/filings/0000074046-25-000028.md) | [7.8](/filings/0000074046-25-000069.md) | [8.5 d](/filings/0001628280-26-065453.md) | [16.4](/filings/0001628280-25-055811.md) | [12.9](/filings/0001628280-26-016822.md) | [11.6](/filings/0001628280-26-041539.md) | [13.1 d](/filings/0001628280-26-065453.md) | [15.5](/filings/0001628280-25-055811.md) | [12.6](/filings/0001628280-26-016822.md) | [14.5](/filings/0001628280-26-041539.md) | [14.4 d](/filings/0001628280-26-065453.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: not reported

## Balance sheet

| Line item | Unit | Q1 FY2024 (2023-10-31) | Q2 FY2024 (2024-01-31) | Q3 FY2024 (2024-04-30) | FY2024 (2024-07-31) | Q1 FY2025 (2024-10-31) | Q2 FY2025 (2025-01-31) | Q3 FY2025 (2025-04-30) | FY2025 (2025-07-31) | Q1 FY2026 (2025-10-31) | Q2 FY2026 (2026-01-31) | Q3 FY2026 (2026-04-30) | FY2026 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [29.6](/filings/0000074046-24-000094.md) | [27.8](/filings/0000074046-24-000021.md) | [46.8](/filings/0000074046-24-000043.md) | [23.5](/filings/0001628280-26-065453.md) | [12.5](/filings/0001628280-25-055811.md) | [22.6](/filings/0000074046-25-000028.md) | [36.5](/filings/0000074046-25-000069.md) | [50.5](/filings/0001628280-26-065453.md) | [42.4](/filings/0001628280-25-055811.md) | [46.9](/filings/0001628280-26-016822.md) | [62.9](/filings/0001628280-26-041539.md) | [73.7](/filings/0001628280-26-065453.md) |
| Current assets | $m | [137](/filings/0000074046-23-000080.md) | [139](/filings/0000074046-24-000021.md) | [159](/filings/0000074046-24-000043.md) | [147](/filings/0001628280-25-044686.md) | [144](/filings/0000074046-24-000094.md) | [149](/filings/0000074046-25-000028.md) | [163](/filings/0000074046-25-000069.md) | [177](/filings/0001628280-26-065453.md) | [170](/filings/0001628280-25-055811.md) | [177](/filings/0001628280-26-016822.md) | [196](/filings/0001628280-26-041539.md) | [209](/filings/0001628280-26-065453.md) |
| Total assets | $m | [289](/filings/0000074046-23-000080.md) | [296](/filings/0000074046-24-000021.md) | [319](/filings/0000074046-24-000043.md) | [355](/filings/0001628280-25-044686.md) | [350](/filings/0000074046-24-000094.md) | [354](/filings/0000074046-25-000028.md) | [370](/filings/0000074046-25-000069.md) | [392](/filings/0001628280-26-065453.md) | [381](/filings/0001628280-25-055811.md) | [388](/filings/0001628280-26-016822.md) | [409](/filings/0001628280-26-041539.md) | [429](/filings/0001628280-26-065453.md) |
| Current liabilities | $m | [52.3](/filings/0000074046-23-000080.md) | [46.2](/filings/0000074046-24-000021.md) | [51.9](/filings/0000074046-24-000043.md) | [66.7](/filings/0001628280-25-044686.md) | [54.8](/filings/0000074046-24-000094.md) | [52.2](/filings/0000074046-25-000028.md) | [57.7](/filings/0000074046-25-000069.md) | [69.2](/filings/0001628280-26-065453.md) | [50.9](/filings/0001628280-25-055811.md) | [51.2](/filings/0001628280-26-016822.md) | [59.9](/filings/0001628280-26-041539.md) | [68.0](/filings/0001628280-26-065453.md) |
| Total liabilities | $m | [103](/filings/0000074046-23-000080.md) | [100](/filings/0000074046-24-000021.md) | [116](/filings/0000074046-24-000043.md) | [144](/filings/0001628280-25-044686.md) | [126](/filings/0000074046-24-000094.md) | [118](/filings/0000074046-25-000028.md) | [123](/filings/0000074046-25-000069.md) | [133](/filings/0001628280-26-065453.md) | [114](/filings/0001628280-25-055811.md) | [116](/filings/0001628280-26-016822.md) | [124](/filings/0001628280-26-041539.md) | [131](/filings/0001628280-26-065453.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [186](/filings/0000074046-25-000028.md) | [196](/filings/0000074046-25-000069.md) | [203](/filings/0000074046-25-000069.md) | [211](/filings/0001628280-26-065453.md) | [224](/filings/0001628280-26-016822.md) | [236](/filings/0001628280-26-041539.md) | [247](/filings/0001628280-26-041539.md) | [259](/filings/0001628280-26-065453.md) | [267](/filings/0001628280-26-016822.md) | [272](/filings/0001628280-26-041539.md) | [285](/filings/0001628280-26-041539.md) | [298](/filings/0001628280-26-065453.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q1 FY2024 (2023-10-31) | Q2 FY2024 (2024-01-31) | Q3 FY2024 (2024-04-30) | Q4 FY2024 (2024-07-31) | Q1 FY2025 (2024-10-31) | Q2 FY2025 (2025-01-31) | Q3 FY2025 (2025-04-30) | Q4 FY2025 (2025-07-31) | Q1 FY2026 (2025-10-31) | Q2 FY2026 (2026-01-31) | Q3 FY2026 (2026-04-30) | Q4 FY2026 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [8.6](/filings/0000074046-24-000094.md) | [9.4 d](/filings/0000074046-25-000028.md) | [19.0 d](/filings/0000074046-25-000069.md) | [23.4 d](/filings/0001628280-26-065453.md) | [10.9](/filings/0001628280-25-055811.md) | [21.4 d](/filings/0001628280-26-016822.md) | [22.7 d](/filings/0001628280-26-041539.md) | [25.2 d](/filings/0001628280-26-065453.md) | [10.3](/filings/0001628280-25-055811.md) | [18.1 d](/filings/0001628280-26-016822.md) | [24.8 d](/filings/0001628280-26-041539.md) | [26.9 d](/filings/0001628280-26-065453.md) |
| Capital expenditure | $m | [8.1](/filings/0000074046-24-000094.md) | [7.5 d](/filings/0000074046-25-000028.md) | [8.2 d](/filings/0000074046-25-000069.md) | [8.3 d](/filings/0001628280-26-065453.md) | [12.8](/filings/0001628280-25-055811.md) | [5.0 d](/filings/0001628280-26-016822.md) | [6.7 d](/filings/0001628280-26-041539.md) | [8.1 d](/filings/0001628280-26-065453.md) | [9.1](/filings/0001628280-25-055811.md) | [5.8 d](/filings/0001628280-26-016822.md) | [6.1 d](/filings/0001628280-26-041539.md) | [13.3 d](/filings/0001628280-26-065453.md) |
| Dividends paid | $m | [1.9](/filings/0000074046-24-000094.md) | [2.0 d](/filings/0000074046-25-000028.md) | [2.0 d](/filings/0000074046-25-000069.md) | [2.0 d](/filings/0001628280-26-065453.md) | [2.1](/filings/0001628280-25-055811.md) | [2.1 d](/filings/0001628280-26-016822.md) | [2.1 d](/filings/0001628280-26-041539.md) | [2.1 d](/filings/0001628280-26-065453.md) | [2.4](/filings/0001628280-25-055811.md) | [2.4 d](/filings/0001628280-26-016822.md) | [2.7 d](/filings/0001628280-26-041539.md) | [2.8 d](/filings/0001628280-26-065453.md) |
| Share repurchases | $m | [0.9](/filings/0000074046-24-000094.md) | [1.7 d](/filings/0000074046-25-000028.md) | [0.1 d](/filings/0000074046-25-000069.md) | [0.1 d](/filings/0001628280-26-065453.md) | [2.0](/filings/0001628280-25-055811.md) | [0.2 d](/filings/0001628280-26-016822.md) | [0.1 d](/filings/0001628280-26-041539.md) | [0.1 d](/filings/0001628280-26-065453.md) | [7.0](/filings/0001628280-25-055811.md) | [5.4 d](/filings/0001628280-26-016822.md) | [0.2 d](/filings/0001628280-26-041539.md) | [0.0 d](/filings/0001628280-26-065453.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2017 (2016-10-31) | Q2 FY2017 (2017-01-31) | Q3 FY2017 (2017-04-30) | Q1 FY2018 (2017-10-31) | Q2 FY2018 (2018-01-31) | Q3 FY2018 (2018-04-30) | Q1 FY2019 (2018-10-31) | Q2 FY2019 (2019-01-31) | Q3 FY2019 (2019-04-30) | Q1 FY2020 (2019-10-31) | Q2 FY2020 (2020-01-31) | Q3 FY2020 (2020-04-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [7,138](/filings/0000074046-17-000063.md) | [7,155](/filings/0000074046-18-000007.md) | [7,164](/filings/0000074046-18-000026.md) | [7,211](/filings/0000074046-18-000081.md) | [7,139](/filings/0000074046-19-000013.md) | [7,222](/filings/0000074046-19-000031.md) | [7,243](/filings/0000074046-19-000072.md) | [7,229](/filings/0000074046-20-000009.md) | [7,253](/filings/0000074046-20-000029.md) | [7,306](/filings/0000074046-19-000072.md) | [7,344](/filings/0000074046-20-000009.md) | [7,288](/filings/0000074046-20-000029.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:20 ET. No prices; not investment advice.